Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
KLF5 protects the intestinal epithelium against Th17 immune response in a murine colitis model
Jason Shieh, Timothy H. Chu, Yang Liu, Julie Kim, Ainara Ruiz de Sabando, Soma Kobayashi, Sui Y. Zee, Brian S. Sheridan, Agnieszka B. Bialkowska, Vincent W. Yang
Jason Shieh, Timothy H. Chu, Yang Liu, Julie Kim, Ainara Ruiz de Sabando, Soma Kobayashi, Sui Y. Zee, Brian S. Sheridan, Agnieszka B. Bialkowska, Vincent W. Yang
View: Text | PDF
Research Article Gastroenterology Inflammation

KLF5 protects the intestinal epithelium against Th17 immune response in a murine colitis model

  • Text
  • PDF
Abstract

Inflammatory bowel disease (IBD) is a chronic illness characterized by dysregulated immune cascades in the intestines, in which the Th17 immune response plays an important role. We demonstrated that mice with intestinal epithelium–specific deletion of Krüppel-like factor 5 (Klf5) developed Th17-dependent colonic inflammation. In the absence of KLF5, there was aberrant cellular localization of phosphorylated STAT3, an essential mediator of the Th17-associated cytokine, IL-22, which is required for epithelial tissue regeneration. In contrast, mitigation of IL-17A with anti–IL-17A neutralizing antibody attenuated colitis in Klf5-deficient mice. There was also a considerable shift in the colonic microbiota of Klf5-deficient mice that phenocopied human IBD. Notably, the inflammatory response due to Klf5 deletion was alleviated by antibiotic treatment, implicating the role of microbiota in pathogenesis. Finally, human colitic tissues had reduced KLF5 levels when compared with healthy tissues. Together, these findings demonstrated the importance of KLF5 in protecting the intestinal epithelium against Th17-mediated immune and inflammatory responses. The mice described herein may serve as a potential model for human IBD.

Authors

Jason Shieh, Timothy H. Chu, Yang Liu, Julie Kim, Ainara Ruiz de Sabando, Soma Kobayashi, Sui Y. Zee, Brian S. Sheridan, Agnieszka B. Bialkowska, Vincent W. Yang

×

Figure 2

Deletion of Klf5 from intestinal epithelial cells increases mortality and alters colonic morphology.

Options: View larger image (or click on image) Download as PowerPoint
Deletion of Klf5 from intestinal epithelial cells increases mortality an...
(A) Kaplan-Meier survival curve of CO and TAM treatment for Klf5Ctrl and Klf5ΔIND mouse genotypes (n = 15). (B) Quantification of clinical scores of CO- and TAM-treated Klf5Ctrl and Klf5ΔIND mice. Max for the clinical score is 12 and quantified with 3 categories: stool consistency, weight loss, and fecal blood (n = 20). (C) H&E staining of whole colon tissue from female Klf5Ctrl and Klf5ΔIND mice treated with CO or TAM (n = 12). (D) Quantification of histological scores of CO- and TAM-treated Klf5Ctrl and Klf5ΔIND mice. Max for the histological score is 11 and quantified with 3 categories: crypt damage, inflammatory cells in lamina propria, and ulcers (n = 20). (E) IHC staining of KLF5 in whole colon tissue from female Klf5Ctrl and Klf5ΔIND mice treated with CO or TAM (n = 5). (F) Quantification for percentage of KLF5+ cells per crypt (n = 5). Data from graphs represent mean ± SEM, **P < 0.01; ***P < 0.001; 1-way ANOVA. Scale bars: 70 μm.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts